Market Overview

UPDATE: Jefferies Raises PT on CME Group on 1Q13 Exchange Preview

Share:
Related CME
GFI Group Shareholders Should Vote Against Proposed Merger With CME, Says ISS
Citi Upgrades CME Group, Shows 17% Upside This Year
CME Glitch Halts Electronic Trading in Some Commodities (Fox Business)

In a report published Monday, Jefferies analyst Daniel T. Fannon reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target from $65.00 to $69.00.

In the report, Fannon noted, “We have lowered our 1Q13 EPS expectations for the traditional equity exchanges, while our numbers for the derivatives exchanges remain relatively unchanged. This mirrors the state of general industry trends, where the outlook for derivatives volume growth is much stronger than equity volume growth. CME and ICE remain our favorite ideas in the group.”

CME Group closed on Friday at $60.48.

Latest Ratings for CME

DateFirmActionFromTo
Jan 2015Deutsche BankMaintainsBuy
Jan 2015CitigroupUpgradesNeutralBuy
Jan 2015CLSADowngradesOutperformUnderperform

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Get Benzinga's Newsletters